Close Menu

NEW YORK (360Dx) – RPS Diagnostics and Atomo Diagnostics announced today that they have entered into a commercial and developmental partnership to create FebriDx, a point-of-care test that identifies clinically significant underlying febrile acute respiratory infections and aids in the differentiation between viral and bacterial infections.

FebriDx uses a fingerstick blood sample to provide clinicians with a rapid assessment of the body's immune response to acute respiratory infections. The disposable test returns results within 10 minutes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.